{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-073079","form_type":"8-K","ticker":"LITS","cik":"0001262104","company_name":"Lite Strategy, Inc.","filed_at":"2023-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.482459+00:00","generated_at":"2026-06-07T07:14:15.879322+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MEI Pharma dismisses BDO as auditor, appoints Deloitte effective Dec 26, 2023","bullets":["Dismissed BDO USA, P.C. as independent auditor on Dec 19, 2023; no adverse opinions or disagreements in recent fiscal years.","Appointed Deloitte & Touche LLP as new auditor effective Dec 26, 2023 after a competitive selection process.","Previously reported material weakness in internal controls over revenue recognition was remediated as of June 30, 2023.","BDO furnished a letter agreeing with the company's statements, filed as Exhibit 16.1."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-073079","json":"https://secwatch.observer/filing/0000950170-23-073079.json","markdown":"https://secwatch.observer/filing/0000950170-23-073079.md","text":"https://secwatch.observer/filing/0000950170-23-073079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1262104/000095017023073079/0000950170-23-073079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1262104/000095017023073079/meip-20231219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T07:14:15.879322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"032cc7aba5dd8e1ef25864236fe4191f9b11ed94","claim":"Lite Strategy, Inc. dismissed BDO USA, P.C. as its auditor.","evidence_excerpt":"On December 19, 2023, the Board of Directors (the Board) of MEI Pharma, Inc. (the Company) after a recommendation by the audit committee of the Board of MEI Pharma, Inc. (the Audit Committee), approved the dismissal of BDO USA, P.C. (BDO) as the Company’s independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1262104/000095017023073079/0000950170-23-073079-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"BDO USA, P.C."}],"fact_type":"auditor_change"},{"claim_id":"56ea8cea54e86b64fd95dae21864178d14730b62","claim":"Lite Strategy, Inc. engaged Deloitte & Touche LLP as its auditor.","evidence_excerpt":"On December 19, 2023, the Board appointed, upon the Audit Committee's recommendation, Deloitte as the Company’s new independent registered public accounting firm effective as of December 26, 2023.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1262104/000095017023073079/0000950170-23-073079-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Deloitte & Touche LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}